Javascript must be enabled to continue!
Flat Serrated Adenomas of the Colorectal Mucosa
View through CrossRef
A total of 47 flat serrated neoplasias of the colorectal mucosa are presented: 44 were flat serrated adenomas and the remaining 3 flat serrated adenocarcinomas arising in flat serrated adenomas. These lesions were found among 600 flat mucosal lesions removed at colonoscopy during a 3‐year period (1992 and 1994) at the Karolinska Hospital. Thirty‐five of the 47 patients (74%) were males and the remaining 12 (26%), females. Depending upon the degree of cellular dysplasia within the epithelium, serrated adenomas were divided into those with low‐grade dysplasia (LGD), when the dysplastic nuclei were present in the deeper half of the epithelium, and those with high‐grade dysplasia (HGD), when the dysplastic nuclei were found even in the upper half of the epithelium. LGD was present in 37 (84.1%) of the 44 serrated adenomas and HGD in the remaining 7 (15.9%). Depending upon the topographic distribution of the dysplastic epithelium within the crypts, flat serrated adenomas were divided into type I, when the dysplastic epithelium was limited to the lower half of the serrated crypts, and type II, when the dysplastic epithelium was even present in the superficial half of the serrated crypts. Of the 44 serrated adenomas, 38 (86.1%) were type I and the remaining 6 (13.9%) type II. The dysplastic epithelium seemed to originate at the base of the crypts and to progress upwards, replacing the scalloped, serrated epithelium of the sides of the crypts. Invasive adenocarcinomas (i.e., with submucosal extension) were seen to arise from flat serrated adenomas with LGD type I (n=2) or with HGD type II (n= 1). This preliminary survey suggests that flat serrated adenomas of the colorectal mucosa may be lesions with a propensity to evolve into invasive adenocarcinoma, irrespective of the degree of the epithelial dysplasia or of their extension along the crypts.
Title: Flat Serrated Adenomas of the Colorectal Mucosa
Description:
A total of 47 flat serrated neoplasias of the colorectal mucosa are presented: 44 were flat serrated adenomas and the remaining 3 flat serrated adenocarcinomas arising in flat serrated adenomas.
These lesions were found among 600 flat mucosal lesions removed at colonoscopy during a 3‐year period (1992 and 1994) at the Karolinska Hospital.
Thirty‐five of the 47 patients (74%) were males and the remaining 12 (26%), females.
Depending upon the degree of cellular dysplasia within the epithelium, serrated adenomas were divided into those with low‐grade dysplasia (LGD), when the dysplastic nuclei were present in the deeper half of the epithelium, and those with high‐grade dysplasia (HGD), when the dysplastic nuclei were found even in the upper half of the epithelium.
LGD was present in 37 (84.
1%) of the 44 serrated adenomas and HGD in the remaining 7 (15.
9%).
Depending upon the topographic distribution of the dysplastic epithelium within the crypts, flat serrated adenomas were divided into type I, when the dysplastic epithelium was limited to the lower half of the serrated crypts, and type II, when the dysplastic epithelium was even present in the superficial half of the serrated crypts.
Of the 44 serrated adenomas, 38 (86.
1%) were type I and the remaining 6 (13.
9%) type II.
The dysplastic epithelium seemed to originate at the base of the crypts and to progress upwards, replacing the scalloped, serrated epithelium of the sides of the crypts.
Invasive adenocarcinomas (i.
e.
, with submucosal extension) were seen to arise from flat serrated adenomas with LGD type I (n=2) or with HGD type II (n= 1).
This preliminary survey suggests that flat serrated adenomas of the colorectal mucosa may be lesions with a propensity to evolve into invasive adenocarcinoma, irrespective of the degree of the epithelial dysplasia or of their extension along the crypts.
Related Results
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract
Introduction: Current study found that about one-third of the incidence of colorectal cancer have genetic related. Hereditary nonpolyposis colorectal cancer...
Association of serum lipids and apolipoprotein E gene polymorphism with the risk of colorectal adenomas
Association of serum lipids and apolipoprotein E gene polymorphism with the risk of colorectal adenomas
OBJECTIVE: To investigate the relationship of serum lipids and apolipoprotein (apoE) gene polymorphism to colorectal adenomas. METHODS: This study took place in the Department of G...
Abstract 1448: Unraveling the oncogenic pathway of serrated polyposis syndrome driven by RNF43 germline mutation
Abstract 1448: Unraveling the oncogenic pathway of serrated polyposis syndrome driven by RNF43 germline mutation
Abstract
Serrated polyps can arise in a sporadic or familial polyposis setting and predispose to colorectal cancer (CRC). Recently, we have identified RNF43 germline...
Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer
Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer
Background and aims: Polypectomy in the colon has been shown to prevent colorectal cancer in both the general population and in familial colorectal cancer. Individuals with a famil...
Hyper-Methylated Loci Persisting from Sessile Serrated Polyps to Serrated Cancers
Hyper-Methylated Loci Persisting from Sessile Serrated Polyps to Serrated Cancers
Although serrated polyps were historically considered to pose little risk, it is now understood that progression down the serrated pathway could account for as many as 15%–35% of c...
Abstract 3806: Mitochondrial DNA (MtDNA) analysis in colorectal neoplasia
Abstract 3806: Mitochondrial DNA (MtDNA) analysis in colorectal neoplasia
Abstract
PURPOSE: Colorectal cancer is the third most common cause of cancer-related deaths in both men and women in the western hemisphere. The prognosis is based o...
Endoscopic Surveillance in Serrated Polyposis Syndrome: Two or Three-Year Intervals. A Noninferiority Randomized Trial
Endoscopic Surveillance in Serrated Polyposis Syndrome: Two or Three-Year Intervals. A Noninferiority Randomized Trial
Abstract
Background:
Serrated polyposis syndrome, the most prevalent colonic polyposis, confers an increased colorectal cancer ...
P307 Colorectal neoplasia risk in patients with inflammatory bowel disease and serrated lesions
P307 Colorectal neoplasia risk in patients with inflammatory bowel disease and serrated lesions
Abstract
Background
The presence of serrated lesions (SLs) is an established risk factor for colorectal neoplasia development in...

